Eradication of penicillin-resistant pneumococci in the nasopharynx with antibiotic combinations including rifampicin: Experiences from the South Swedish Pneumococcal Intervention Project

Scandinavian Journal of Infectious Diseases

Volumn 29, Issue 4, 1997, Pages 373-375

  Ekdahl, Karl ^a   Holmdahl, Torsten ^a   Vejvoda, Mirek ^b   Persson, Kristina ^c  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b HELSINGBORG HOSPITAL   (Sweden)

^c Regional Centre of Communicable Disease Control   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLINDAMYCIN; ERYTHROMYCIN; RIFAMPICIN;

ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CARRIER; BACTERIUM CULTURE; CHILD; CLINICAL ARTICLE; HUMAN; INFANT; NASOPHARYNX; PENICILLIN RESISTANCE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

EID: 0030697921     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365549709011833     Document Type: Article

References (8)

1. Ekdahl K, Kamme C. Increasing resistance to penicillin in Streptococcus pneumoniae in southern Sweden. Scand J Infect Dis 26: 301-5, 1994.
2. Forsgren A, Walder M. Antimicrobial susceptibility of bacterial isolates in south Sweden including a 13-year follow-up study of some respiratory tract pathogens. APMIS 102: 227-35, 1994.
3. Regional Centre for Communicable Disease Control, Malmö: Guidelines for the management of penicillin-resistant Streptococcus pneumoniae [in Swedish]. Svensk Medicin 50: 135-6, 1996.
4. Devine LF, Johnson DP, Hagerman CR, Pierce WE, Rhode SL 3d, Peckinpaugh RO. Rifampin. Levels in serum and saliva and effect on the meningococcal carrier state. JAMA 214: 1055-9, 1970.
5. Eliasson I, Holst E, Mölstad S, Kamme C. Emergence and persistence of beta-lactamase producing bacteria in the upper respiratory tract in children following treatment with betalactam antibiotics. Am J Med 88: 51S-5S, 1990.
6. Skulnick M, Small GW, Lo P, Patel MP, Porter CR, Low DE, Matsumura S, Mazzulli T. Evaluation of accuracy and reproducibility of E test for susceptibility testing of Streptococcus pneumoniae to penicillin, cefotaxime, and ceftriaxone. J Clin Microbiol 33: 2334-7, 1995.
7. Koornhof HJ, Jacobs MR, Ward JI, Appelbaum PC, Hallet FA. Therapy and control of antibiotic-resistant disease. In: Schlessinger D, ed. Microbiology 1979. Washington DC: American Society for Microbiology, 286-9, 1979.
8. Rauch AM, O'Ryan M, Van R, Pickering LK. Invasive disease due to multiply resistant Streptococcus pneumoniae in a Houston, Texas, day-care center. Am J Dis Child 144: 923-7, 1990.